Contributors

Kenneth Buetow is the director of the National Cancer Institute Center for Biomedical Informatics and Information Technology. He is also an intramural researcher at NCI, working on genomics. In 2004, Buetow and colleagues launched the cancer Biomedical Informatics Grid (caBIG) to help researchers manage and integrate the ever-growing dataset of clinical, genomic, imaging, pathological, and proteomic

Written byThe Scientist
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Kenneth Buetow is the director of the National Cancer Institute Center for Biomedical Informatics and Information Technology. He is also an intramural researcher at NCI, working on genomics. In 2004, Buetow and colleagues launched the cancer Biomedical Informatics Grid (caBIG) to help researchers manage and integrate the ever-growing dataset of clinical, genomic, imaging, pathological, and proteomic observations (Click here to read about it ). caBIG now involves 1000 people, from 80 institutions, employing 40 software tools to incorporate all types of research information. "What's been rewarding is how enthusiastically received the [tool] has been by the broader biomedical community," he says.

Michael Stebbins has worked as a legislative fellow in the US Senate, a public policy fellow at the NHGRI, and a senior editor at Nature Genetics. Currently he is the director of biology policy for the Federation of American Scientists and the president of the Scientists and Engineers for ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies